BEPACT- Lung: Impact of Patient Characteristics on Pneumo-oncologists Non Small Cell Lung Cancer (NSCLC) Systemic Treatment Decision in Belgium

CompletedOBSERVATIONAL
Enrollment

215

Participants

Timeline

Start Date

June 3, 2019

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions
Stage IV Non-small Cell Lung Cancer
Interventions
OTHER

None - Common practice

None - Common practice

Trial Locations (21)

Unknown

UZA, Antwerp

ZNA Middelheim, Antwerp

Imelda Ziekenhuis, Bonheiden

CHIREC, Brussels

Cliniques Universitaires Saint-Luc UCL Bruxelles, Brussels

UZ Brussel, Brussels

CH de Charleroi, Charleroi

UZ Gent, Ghent

CH Jolimont, Haine-Saint-Paul

Jessa Ziekenhuis, Hasselt

Az Groeninghe Kortrijk, Kortrijk

UZ Leuven, Leuven

CHC Liège, Liège

CHR Citadelle, Liège

CHU de Liège, Liège

CHU UCL Namur, site Godinne, Namur

Clinique St-Pierre Ottignies, Ottignies

AZ Delta, Roeselare

AZ St Nikolaas, Saint-Nicolas

St Trudo Ziekenhuis, Sint-Truiden

AZ Turnhout, Turnhout

All Listed Sponsors
lead

MSD Belgium BVBA

INDUSTRY

NCT03959137 - BEPACT- Lung: Impact of Patient Characteristics on Pneumo-oncologists Non Small Cell Lung Cancer (NSCLC) Systemic Treatment Decision in Belgium | Biotech Hunter | Biotech Hunter